Coronavirus
Health & Medicine
The rise and fall in Australia’s life expectancy during the pandemic
Australia is a valuable international case study into life expectancy trends during the COVID-19 pandemic
Health & Medicine
What we now know about long COVID and our brains
Almost three years into the global pandemic, we may know more about Post-COVID-19 Neurological Syndrome (PCNS), but there’s a critical need for more global collaboration
Health & Medicine
The COVID-19 vaccine difference between men and women
New research finds there is a sex difference when it comes to the effectiveness and side effects of COVID-19 vaccines
Health & Medicine
Reducing COVID-19 transmission without costing the Earth
While opening windows reduces COVID-19 spread, it also increases buildings’ energy use – new research has tested more efficient alternatives
Health & Medicine
Uncovering the triggers of severe COVID-19 in kids
New research finds that proteins in the blood may tell us the triggers of severe COVID-19 in children
Health & Medicine
Q&A
Q&A: What we do (and don’t) know about Omicron
The latest COVID-19 variant, Omicron, has sparked international travel bans, stricter quarantine and a lot of “hype” worldwide – but we still have a lot to learn about the mutation
Health & Medicine
Choose (vaccinated) life
Around four per cent of people hospitalised with COVID-19 are fully vaccinated – 96 per cent aren’t. One Emergency doctor says there’s no escaping the life-saving truth that vaccines do work
Health & Medicine
NSW should be ‘okay’ opening up
New modelling suggests that NSW – as well Victoria and ACT – should have confidence that opening up will be ‘okay’ at 70 to 80 per cent double vaccinated
Health & Medicine
The facts of vaccinating our kids against COVID-19
Does the risk versus benefit equation justify having my Year 7 child vaccinated against COVID-19? The answer is yes
Health & Medicine
What if Victoria cannot eliminate Delta this time?
If the current hard lockdown in Victoria doesn’t see a dramatic reduction in COVID-19 cases by 2 September, what are the options on the table?